Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06980142
PHASE2
A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sponsor: Keymed Biosciences Co.Ltd
View on ClinicalTrials.gov
Summary
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Explore the Efficacy and Safety of CM512 Injection in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Official title: A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating CM512 Injection in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
204
Start Date
2025-06-20
Completion Date
2028-03-17
Last Updated
2025-05-20
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
CM512
Administered SC
DRUG
Placebo
Administered SC